Adjuvant Chemotherapy in Resectable Gallbladder Cancer is Underutilized Despite Benefits in Node-Positive Patients
- PMID: 32989657
- DOI: 10.1245/s10434-020-09167-1
Adjuvant Chemotherapy in Resectable Gallbladder Cancer is Underutilized Despite Benefits in Node-Positive Patients
Comment in
-
Reply to "Comment on: Adjuvant Chemotherapy in Resectable Gallbladder Cancer is Underutilized Despite Benefits in Node-Positive Patients".Ann Surg Oncol. 2020 Dec;27(Suppl 3):942-943. doi: 10.1245/s10434-020-09170-6. Epub 2020 Sep 25. Ann Surg Oncol. 2020. PMID: 32978701 No abstract available.
Comment on
-
Adjuvant Chemotherapy in Resectable Gallbladder Cancer is Underutilized Despite Benefits in Node-Positive Patients.Ann Surg Oncol. 2021 Mar;28(3):1466-1480. doi: 10.1245/s10434-020-08973-x. Epub 2020 Aug 4. Ann Surg Oncol. 2021. PMID: 32749621
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical